Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

BACKGROUND: The molecular drivers of early sporadic Parkinson’s disease (PD) remain unclear, and the presence of widespread end stage pathology in late disease masks the distinction between primary or causal disease-specific events and late secondary consequences in stressed or dying cells. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Toomey, Christina E., Heywood, Wendy E., Evans, James R., Lachica, Joanne, Pressey, Sarah N., Foti, Sandrine C., Al Shahrani, Mesfer, D’Sa, Karishma, Hargreaves, Iain P., Heales, Simon, Orford, Michael, Troakes, Claire, Attems, Johannes, Gelpi, Ellen, Palkovits, Miklos, Lashley, Tammaryn, Gentleman, Steve M., Revesz, Tamas, Mills, Kevin, Gandhi, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461181/
https://www.ncbi.nlm.nih.gov/pubmed/36076304
http://dx.doi.org/10.1186/s40478-022-01424-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461181/
https://www.ncbi.nlm.nih.gov/pubmed/36076304
http://dx.doi.org/10.1186/s40478-022-01424-6

Ejemplares similares